LOGIN

Research papers

USA Pricing Data

  • 28 November 2024
Read More

Explore the pinnacle of our contributions at ISPOR 2023

  • 22 November 2023
Read More

Value-based price forecasting: an accurate method for orphan drugs?

  • By Anstee K, Rao J
  • 25 May 2023
Read More

Importance of time horizon and analogue selection for value-based pricing of cell and gene therapies

  • By Anstee K, Rao J
  • 12 May 2023
Read More

Solving the Chinese puzzle: What determines reimbursement price in China?

  • By Song X, Kodabuckus S, Patel P
  • 23 December 2022
Read More

Regulatory and reimbursement landscape for Cell and Gene Therapies across Europe

  • By Beards S, Song X, Kodabuckus S
  • 23 December 2022
Read More

Suitability of value-based price forecasting in a crowded landscape: A case study in rheumatoid arthritis

  • By Anstee K, Patel P
  • 13 December 2022
Read More

The relationship between value and price in the free-pricing period and post-assessment price in Germany, a case study in rheumatoid arthritis

  • By Cigerli S, Anstee K, Patel P
  • 3 December 2022
Read More

The National Pricing and Reimbursement Process in China: A 2021 Update

  • 25 June 2022
Read More

List prices for Medicare negotiation-eligible medicines targeted by Build Back Better drug pricing provisions estimated to be reduced by over 40% on average.

  • 8 June 2022
Read More

Yearly Archives

Stay Informed

Sign up to receive the latest news and trends
straight into your inbox from GPI